Advances in 3D Bioprinting and Microfluidics for Organ-on-a-Chip Platforms.

The convergence of 3D bioprinting and microfluidics has revolutionized the development of organ-on-a-chip platforms, offering unprecedented opportunities in biomedical research and tissue engineering. This comprehensive review delves into the latest advancements in these technologies, highlighting their significance and transformative potential. The introduction provides an overview of 3D bioprinting, microfluidics, and organ-on-a-chip systems, emphasizing their critical roles in replicating physiological conditions and enhancing the precision of biomedical studies. The review aims to move beyond fundamental concepts, focusing on recent innovations and applications that have propelled these technologies to the forefront of research. In the realm of 3D bioprinting, the review explores the evolution of bioprinting techniques, including extrusion-based, inkjet, and laser-assisted methods and polymer-based biomaterials as matrices for in vitro tissue modeling. Technological breakthroughs such as high-resolution bioprinting, multi-material printing, and advanced bioink development are discussed, showcasing their impact on creating complex tissue structures. Innovations in bioinks, including printable polymer-based hydrogels and decellularized matrix bioinks, are highlighted for their ability to replicate tissue microenvironments more accurately. The review also covers microfluidic innovations, detailing advances in design and fabrication, including 3D printing and sensor integration. Key innovations in fluid dynamics and tissue integration are examined, demonstrating how these advancements enhance tissue modeling and mimic physiological perfusion. Developing multi-organ-on-a-chip systems and connecting multiple tissue types for systemic studies are also explored. Hence, integrating 3D bioprinting and microfluidics is a focal point, with discussions on how their convergence enhances organ-on-a-chip platforms. The review concludes by examining current challenges, such as scalability and regulatory hurdles, and future directions, including emerging technologies like 4D bioprinting and AI-driven tissue design.